MG

Mariano A. Garcia-Blanco

DU Duke University: 7 patents #166 of 2,315Top 8%
University Of Texas System: 6 patents #431 of 6,559Top 7%
VI Virxsys: 5 patents #1 of 18Top 6%
University of California: 2 patents #4,561 of 18,278Top 25%
VU Vanderbilt University: 1 patents #725 of 1,609Top 50%
MS Menarini Silicon Biosystems S.P.A.: 1 patents #7 of 31Top 25%
Johnson & Johnson: 1 patents #4,762 of 7,810Top 65%
📍 Galveston, TX: #10 of 342 inventorsTop 3%
🗺 Texas: #7,815 of 125,132 inventorsTop 7%
Overall (All Time): #243,650 of 4,157,543Top 6%
18
Patents All Time

Issued Patents All Time

Showing 1–18 of 18 patents

Patent #TitleCo-InventorsDate
12359204 Soluble interleukin-7 receptor (SIL7R) modulating therapy to treat autoimmune diseases and cancer Gaddiel Galarza-Munoz, Shelton S. Bradrick 2025-07-15
12247206 Soluble interleukin-7 receptor (SIL7R) modulating therapy to treat autoimmune diseases and cancer Gaddiel Galarza-Munoz, Shelton S. Bradrick 2025-03-11
12203138 Method to identify subjects at higher risk to develop an autoimmune disease based on genetic and/or phenotypic screening for epistatic variants in DDX39B (RS2523506) and IL7R (RS6897932) Gaddiel Galarza-Munoz, Simon G. Gregory, Farren B. S. Briggs, Lisa F. Barcellos, Shelton S. Bradrick +2 more 2025-01-21
11807853 Soluble interleukin-7 receptor (sIL7R) modulating therapy to treat autoimmune diseases and cancer Gaddiel Galarza-Munoz, Shelton S. Bradrick 2023-11-07
11567081 Method of isolating circulating tumor cells Galla Chandra Rao, Mark Carle Connelly, Andrew J. Armstrong, Rhonda L. Bitting 2023-01-31
11118186 Soluble interleukin-7 receptor (sIL7R) modulating therapy to treat autoimmune diseases and cancer Gaddiel Galarza-Munoz, Shelton S. Bradrick 2021-09-14
10961581 Method to identify subjects at higher risk to develop an autoimmune disease based on genetic and/or phenotypic screening for epistatic variants in DDX39B (RS2523506) and IL7R (RS6897932) Gaddiel Galarza-Munoz, Simon G. Gregory, Farren B. S. Briggs, Lisa F. Barcellos, Shelton S. Bradrick +2 more 2021-03-30
10161939 Method of isolating circulating tumor cells Galla Chandra Rao, Mark Carle Connelly, Andrew J. Armstrong, Rhonda L. Bitting 2018-12-25
9845481 Synthetic regulation of gene expression Matthew S. Marengo 2017-12-19
9284575 Synthetic regulation of gene expression Matthew S. Marengo 2016-03-15
8883753 Expression of apoAI and variants thereof using spliceosome mediated RNA trans-splicing Madaiah Puttaraju, Edward Otto, Gerard J. McGarrity, Gary Temple 2014-11-11
8158344 Methods and compositions for correlating genetic markers with multiple sclerosis Jonathan L. Haines, Simon G. Gregory, Silke Schmidt, Margaret A. Pericak-Vance 2012-04-17
8053232 Correction of alpha-1-antitrypsin genetic defects using spliceosome mediated RNA trans splicing Madaiah Puttaraju, Edward Otto, Gerard J. McGarrity, Gary Temple, Lloyd G. Mitchell +2 more 2011-11-08
7968334 Expression of apoAI and variants thereof using spliceosome mediated RNA trans-splicing Madaiah Puttaraju, Edward Otto, Gerard J. McGarrity, Gary Temple 2011-06-28
7879321 Use of RNA trans-splicing for antibody gene transfer and antibody polypeptide production Gerard J. McGarrity, Madaiah Puttaraju 2011-02-01
7871795 Targeted trans-splicing of highly abundant transcripts for in vivo production of recombinant proteins Gerard J. McGarrity 2011-01-18
6280978 Methods and compositions for use in spliceosome mediated RNA trans-splicing Lloyd G. Mitchell 2001-08-28
6083702 Methods and compositions for use in spliceosome mediated RNA trans-splicing Lloyd G. Mitchell 2000-07-04